Skip to main content

Pharmacy Technology

  • DLife offers travel tips to diabetics

    WESTPORT, Conn. — A diabetes community network is offering tips to diabetics that are traveling this holiday season.

     

    DLife emphasized that since diabetes doesn't take a holiday, managing the condition shouldn't either. On its website, DLife.com, the company is offering such tips to diabetics as:

  • Pfizer on kidney cancer drug: Extends lives of patients

    NEW YORK — Pfizer got promising results from a late-stage clinical trial of a cancer treatment, the drug maker said Friday.

     

    Pfizer announced results of the phase-3 “AXIS 1032” trial of the kidney cancer drug axitinib, saying that it “significantly” extended the lives of patients with advanced renal cell carcinoma compared with Nexavar (sorafenib), made by Bayer HealthCare and Onyx Pharmaceuticals.

     

     

  • Subs keeps up with urban trend

    NEW YORK — A new urban fashion accessory has hit the market.

    Hatch Ventures recently introduced Subs, designed for consumers who wear baggy pants well below the waistline. Like traditional suspenders, Subs are designed to keep pants from falling down by cinching around the waist and are worn underneath a shirt. The wearer can control how long they want their pants to "sag," and prevent pants from falling any lower.

    Subs carry a suggested retail price of $34.95 and currently are available on Hatch Ventures' website, HatchVentures.com.

  • Novartis looks to expand pipeline, focuses on long-term growth

    BASEL, Switerland — Swiss drug maker Novartis will focus on innovation as part of a program for long-term growth, the company said Wednesday.

    Novartis touted its research and development pipeline of 142 drugs in clinical trials, 35% of which are in phase 3 or undergoing regulatory review, as well as a plan to submit 30 more drugs for regulatory review by the end of 2012. The company also plans to continue investing in vaccine development.

  • Supervalu EVP transitions to new role

    MINNEAPOLIS — A 20-year veteran at Supervalu will become a senior counselor outside of the company for one year.

    David Boehnen, who as EVP was responsible for legal, business development, real estate and store development, as well as government affairs, will leave his post at the retailer but will serve as a senior counselor for Supervalu president and CEO Craig Herkert for one year.

    The change is effective Dec. 15.

     

  • New Supervalu survey reveals that food brings families together

    MINNEAPOLIS — Food is the most important aspect of the holiday season and unites families, according to a new survey conducted by Harris Interactive for retail giant Supervalu.

  • Cardinal Health to acquire pharmaceutical distributor Kinray

    DUBLIN, Ohio Cardinal Health is looking to expand the pharmaceutical segment of its business by acquiring a pharmaceutical distributor serving the New York metropolitan area.

    The company said its acquisition of Kinray for $1.3 billion in an all-cash transaction would significantly expand its ability to serve retail independent pharmacies in the northeastern United States. Kinray currently serves more than 2,000 retail independent pharmacy customers as a distributor of both branded and generic pharmaceuticals.

  • Coalition urges Congress to repeal pending FSA change, calls policy 'unwarranted'

    WASHINGTON — A coalition of six associations, including the Consumer Healthcare Products Association and the National Association of Chain Drug Stores, on Thursday called on Congress to repeal the requirement that prevents consumers from using their flexible spending accounts to purchase over-the-counter medicines without a prescription as of Jan. 1.

     

X
This ad will auto-close in 10 seconds